The FASLG gene helps immune cells send a signal that tells worn-out, infected, or extra cells when to die, which keeps the immune system balanced. If it does not work properly, immune cells may build up instead of clearing away, which can lead to enlarged lymph nodes or spleen, autoimmune problems, and low blood counts. Pathogenic variants in the FASLG gene are a rare cause of autoimmune lymphoproliferative syndrome. Most people never hear about this gene unless it appears in genetic testing for immune problems.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes hold the code for proteins, which do much of the cell’s work. Other genes mainly control when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. If you want to look into this topic more closely, you can learn more in the LearnHub.
Overview
FASLGGene function
What if the gene works
The FASLG gene helps immune cells send signals for controlled cell death. This helps your body remove damaged, infected, or unneeded cells and keeps immune responses more balanced.
Risk
What if the gene does not work
Variants in the FASLG gene can cause an autoimmune lymphoproliferative condition, often with enlarged lymph nodes or spleen and immune related low blood counts. Milder to more severe variants may influence when problems begin and how strongly they affect immunity.
Treatment
What does that mean for your treatment
No FASLG-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the FASLG gene. The FASLG pathway is being studied as a biomarker and drug target in cancer and immune conditions, but this has not yet led to guideline-based treatment choices for people carrying these variants.
Conditions associated with FASLG
Gene function
What if the gene works
Your immune system uses the FASLG gene to send clear stop signals between cells. Its protein sits on the surface of certain immune cells and helps trigger programmed cell death (a controlled way for cells to shut down). This keeps immune activity more balanced and supports normal cell turnover.
The FASLG gene helps certain cells undergo programmed cell death when they are no longer needed. This controlled shutdown lets the body clear cells in an orderly way.
FASLG helps the immune system trim back activated cells once their job is done. This is part of how the FASLG gene works in the immune system to keep responses more controlled.
Some T cells and natural killer cells display the FASLG protein to signal infected or damaged cells to shut down. This supports everyday immune defense by helping remove harmful cells in a targeted way.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FASLG gene can reduce how much Fas ligand is made, keep it from reaching the cell surface, or weaken its binding to the Fas receptor, so cell death signaling is less effective. This explains how variants in the FASLG gene affect protein function, from milder changes that leave partial activity to more severe variants that nearly abolish signaling. In autoimmune lymphoproliferative syndrome linked to the FASLG gene, more disruptive variants may be associated with earlier onset.
How variants are linked to conditions
Pathogenic variants in the FASLG gene can cause autoimmune lymphoproliferative syndrome, often called ALPS. This rare condition may involve enlarged lymph nodes or spleen, autoimmune low blood counts, and a higher chance of lymphoma. The link between FASLG gene variants and autoimmune lymphoproliferative syndrome is well established, although FASLG is a much less common cause than some related genes.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, one well-understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to FASLG. In families with a harmful FASLG change, the main factor is whether that change is present, while day-to-day habits have not been shown to clearly change that genetic risk.
Inheritance of FASLG variants
For families asking how FASLG gene variants are inherited, the best-established pattern is autosomal recessive for FASLG-related autoimmune lymphoproliferative syndrome. This means a child usually inherits one altered copy of the FASLG gene from each parent. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern affects sons and daughters equally.
What does my FASLG result mean for my family?
For FASLG, the best-known inherited condition is usually passed down in a recessive pattern. This means close relatives may be healthy carriers without knowing it, and brothers or sisters could also be affected or be carriers. Family planning questions often center on whether both parents carry the same changed FASLG copy.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for FASLG variants usually uses a blood sample or saliva sample. A lab reads the FASLG gene and compares it with the usual DNA sequence to look for changes, often as part of a multi gene immune panel or broader sequencing. Results may show no variant, a benign variant, or a variant linked to disease.
When should I consider getting a genetic test?
Testing for FASLG may be considered if someone has signs of a rare inherited immune condition, such as ongoing swollen lymph nodes or an enlarged spleen, repeated low blood counts caused by the immune system, or a strong family history of this pattern. It can also help clarify the cause when these problems start in childhood or run in families.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you varies with the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medication may work better for some people, have less effect in others, or cause more side effects in people who are more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medications. It studies gene-drug patterns to better explain why the same treatment may work differently from one person to another. With many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment choices. To learn more about this topic, additional details are available in the LearnHub.
Drugs influenced by the FASLG gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, unusual reactions, or whether a treatment is right for you, talk with your doctor or pharmacist.
History
The FASLG gene entered genetics during the intense study of programmed cell death in the 1990s, when researchers were piecing together how the body removes unwanted cells. From these first observations, research expanded steadily. Scientists identified Fas ligand as the partner to the Fas receptor, helping connect earlier work in immunology with the growing field of cell death research. This was an important step because it linked inherited gene changes to immune system conditions and to rare illnesses in which cell turnover is not well controlled. As medical science evolved, so did understanding of this gene. FASLG remains part of the broader story of how apoptosis research reshaped modern immunology and cancer biology.